No Prescription |
 |
 | ||
|
LETROZ Femara |
|
| ||
No Prescription » Prescription Drugs 10 » LETROZ Femara This medication is used in women who have experienced menopause (change of life; end of monthly menstrual periods) to: treat breast cancer that has spread within the breast or to other areas of the body. treat early breast cancer in women who have already been treated with surgery radiation and/or chemotherapy. Letrozole is sometimes used right after these treatments and sometimes after 5 years of treatment with a medication called tamoxifen (Nolvadex). Letrozole is used to stop any cancer cells that remain after these treatments from spreading. Letrozole is in a class of medications known as nonsteroidal aromatase inhibitors. It decreases the amount of estrogen produced by the body. This can slow or stop the growth of some breast tumors that need estrogen to grow.Letrozole is usually taken once a day with or without food. Try to take letrozole at around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain anything you do not understand. Take letrozole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.You may need to take letrozole for several years or longer. Continue to take letrozole even if you feel well. Do not stop taking letrozole without talking to your doctor.If you forget to take a dose of letrozole take the missed dose as soon as you remember it. However if it is almost time for your next dose skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed dose and do not take more than one dose of letrozole in one day. Buy LETROZ Femara and other Prescription Drugs 10 products online at Medstore. 951
About LETROZ Femara: Product Type: Prescription Drugs 10 LETROZ ( Femara Generic Letrozole ) LETROZ (Femara Generic Letrozole) Femara Generic Letrozole 2.5 mg Tab 50 Femara Generic Letrozole LETROZ
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
